Workflow
Corteva Q2 Preview: Potential Benefit From Positive Biofuel Policy In Brazil

I assigned a ‘ buy’ rating to Corteva (NYSE: CTVA ) in November 2024, highlighting its low commodity and raw material costs. Since then, the stock price has surged by more than 30% and significantly outperformed the S&P 500 Index (Analyst’s Disclosure:I/we have a beneficial long position in the shares of CTVA either through stock ownership, options, or other derivatives. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I h ...